[
  {
    "ts": null,
    "headline": "How Investors May Respond To Piper Sandler Companies (PIPR) Adding Stuart Essig To Its Board",
    "summary": "Piper Sandler Companies recently elected Stuart M. Essig, Ph.D., to its board of directors, expanding the board from nine to ten members and appointing him to the Audit Committee for an initial term running through the 2026 annual shareholder meeting. Essig’s long career leading and advising healthcare and medical technology businesses, including his roles at Integra LifeSciences and IDEXX Laboratories, aligns closely with sectors that matter for Piper Sandler’s investment banking...",
    "url": "https://finnhub.io/api/news?id=2160e68906812445e80bffc8123c739f37c168941be625382033f913be93a5e4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770337387,
      "headline": "How Investors May Respond To Piper Sandler Companies (PIPR) Adding Stuart Essig To Its Board",
      "id": 138370733,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "Piper Sandler Companies recently elected Stuart M. Essig, Ph.D., to its board of directors, expanding the board from nine to ten members and appointing him to the Audit Committee for an initial term running through the 2026 annual shareholder meeting. Essig’s long career leading and advising healthcare and medical technology businesses, including his roles at Integra LifeSciences and IDEXX Laboratories, aligns closely with sectors that matter for Piper Sandler’s investment banking...",
      "url": "https://finnhub.io/api/news?id=2160e68906812445e80bffc8123c739f37c168941be625382033f913be93a5e4"
    }
  }
]